Abstract
Purpose
To lower the rate of cutaneous complications after transcatheter arterial treatment for hepatocellular carcinoma (HCC) via the internal mammary artery (IMA) we retrospectively assessed the complications.
Materials and methods
We reviewed cutaneous complications in 14 patients with 18 HCCs who had undergone 17 treatment procedures via the IMA, including selective transcatheter arterial infusion chemotherapy with Lipiodol (Lip-TAI) (n = 3), selective Lip-TAI + transcatheter arterial embolization (TAE) (n = 3), nonselective Lip-TAI (n = 1), nonselective Lip-TAI + TAE (n = 5), and nonselective TAE (n = 5). The filling and nonfilling of subcutaneous vessels with Lipiodol was examined on postoperative computed tomography (CT) scans.
Results
Skin rash (n = 3) and ulceration (n = 1) occurred after 4 of 17 (24%) procedures: two of three selective Lip-TAI procedures and two of five nonselective Lip-TAI + TAE procedures. The doses of chemotherapeutic agents for tumor sizes in selective Lip-TAI procedures were higher than those in selective Lip-TAI + TAE procedures. Cutaneous complications were encountered after two of three procedures with filling but not after any of eight procedures without filling.
Conclusion
A lower dose of chemotherapeutic agents may be less risky when undertaking a selective procedure via the IMA for HCC. If nonselective, TAE alone may be less risky. Postoperative CT may be helpful for predicting cutaneous complications.
Similar content being viewed by others
References
Kajiwara K, Kakizawa H, Hieda M, Tachikake T, Ishikawa M, Tani C, et al. Case report: an intractable skin ulcer after transcatheter arterial chemoembolization via the right internal mammary artery in a patient with hepatocellular carcinoma. Rinsho Hoshasen 2010;55:455–459.
Hieda M, Toyota N, Kakizawa H, Hirai N, Tachikake T, Matsuura N, et al. Evaluation of hepatocellular carcinoma supplied by the right inferior phrenic artery at initial treatment. J Comput Assist Tomogr 2008;32:877–881.
Kim HC, Chung JW, Choi SH, Jae HJ, Lee W, Park JH. Internal mammary arteries supplying hepatocellular carcinoma: vascular anatomy at digital subtraction angiography in 97 patients. Radiology 2007;242:925–932.
Miyayama S, Matsui O, Taki K, Minami T, Ryu Y, Ito C, et al. Extrahepatic blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization. Cardiovasc Intervent Radiol 2006;29:39–48.
Kim HC, Chung JW, Lee W, Jae HJ, Park JH. Recognizing extrahepatic collateral vessels that supply hepatocellular carcinoma to avoid complications of transcatheter arterial chemoembolization. Radiographics 2005;25(suppl 1):S25–S39.
Kim JH, Chung JW, Han JK, Park JH, Choi BI, Han MC. Transcatheter arterial embolization of the internal mammary artery in hepatocellular carcinoma. J Vasc Interv Radiol 1995;6:71–74; discussion 75–7.
Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982;144:485–494.
Kim HC, Chung JW, Choi SH, Yoon JH, Lee HS, Jae HJ, et al. Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis. J Vasc Interv Radiol 2007;18:611–619.
Nakai M, Sato M, Kawai N, Minamiguchi H, Masuda M, Tanihata H, et al. Hepatocellular carcinoma: Involvement of the internal mammary artery. Radiology 2001;219:147–152.
Nakai M, Sato M, Kawai N, Minamiguchi H, Masuda M, Tanihata H, et al. Analysis of hepatocellular carcinoma fed by internal thoracic artery. Jpn Intervent Radiol 1999;14:202–207.
Shin SW. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009;10:425–434.
Arora R, Soulen MC, Haskal ZJ. Cutaneous complications of hepatic chemoembolization via extrahepatic collaterals. J Vasc Interv Radiol 1999;10:1351–1356.
Lee JH, Chon CY, Ahn SH, Moon BS, Kim JH, Paik YH, et al. An ischemic skin lesion after chemoembolization of the right internal mammary artery in a patient with hepatocellular carcinoma. Yonsei Med J 2001;42:137–141.
Gabella G. Cardiovascular system. In: William PL, editor. Gray’s anatomy. 38th edn. London: Churchill Livingstone; 1995. p. 1534–1535.
UICC: TMN classification of malignant tumors. 7th edn. New York: Wiley-Blackwell; 2009.
Couinaud C. Le foie: études anatomiques et chirurgicales. Paris: Masson; 1957. p. 9–12.
Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003;14:S199–S202.
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al. Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL conference-European Association for the Study of the Liver. J Hepatol 2001;35:421–430.
Murakami M, Kuroda Y, Nishimura S, Sano A, Okamoto Y, Taniguchi T, et al. Intraarterial infusion chemotherapy and radiotherapy with or without surgery for patients with locally advanced or recurrent breast cancer. Am J Clin Oncol 2001;24:185–191.
Takizawa K, Shimamoto H, Ogawa Y, Yoshimatsu M, Yagihashi K, Nakajima Y, et al. Development of a new subclavian arterial infusion chemotherapy method for locally or recurrent advanced breast cancer using an implanted catheter-port system after redistribution of arterial tumor supply. Cardiovasc Intervent Radiol 2009;32:1059–1066.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kajiwara, K., Kakizawa, H., Takeuchi, N. et al. Cutaneous complications after transcatheter arterial treatment for hepatocellular carcinoma via the internal mammary artery: how to avoid this complication. Jpn J Radiol 29, 307–315 (2011). https://doi.org/10.1007/s11604-011-0559-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-011-0559-9